1. PROTAC Epigenetics
  2. PROTACs Epigenetic Reader Domain
  3. LGF308

LGF308 is a PROTAC degrader of BRD4 that exhibits selective cytotoxicity toward cancer cells over normal cells. LGF308 mediates the formation of a ternary complex between BRD4 and DCAF11 to achieve BRD4 degradation. LGF308 induces tumor cell apoptosis by upregulating apoptosis-related proteins. LGF308 inhibits tumor cell proliferation and migration in breast cancer and triple-negative breast cancer cell lines. LGF308 can be used for the research of breast cancer.
(Pink: BRD4 ligand (HY-78695); Blue: DCAF11 ligand (HY-W288798); Black: linker).

For research use only. We do not sell to patients.

LGF308

LGF308 Chemical Structure

CAS No. : 3061406-69-4

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All PROTACs Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

LGF308 is a PROTAC degrader of BRD4 that exhibits selective cytotoxicity toward cancer cells over normal cells. LGF308 mediates the formation of a ternary complex between BRD4 and DCAF11 to achieve BRD4 degradation. LGF308 induces tumor cell apoptosis by upregulating apoptosis-related proteins. LGF308 inhibits tumor cell proliferation and migration in breast cancer and triple-negative breast cancer cell lines. LGF308 can be used for the research of breast cancer[1]. (Pink: BRD4 ligand (HY-78695); Blue: DCAF11 ligand (HY-W288798); Black: linker).

In Vitro

LGF308 (10 nM-1 μM; 12 h) potently induces BD1 degradation in BD1-HEK293T reporter cells at concentrations as low as 10 nM for 12 h[1].
LGF308 (0.1-5 μM; 3-9 h) induces time- and concentration-dependent degradation of BRD4 in MDA-MB-231 cells, with DC50 values of 0.50 μM (long isoform) and 0.23 μM (short isoform) and maximal degradation of >90% at 5 μM for 9 h[1].
LGF308 (1 μM) induced BRD4 degradation in MDA-MB-231 cells is dependent on the ubiquitin-proteasome pathway, not the lysosomal pathway[1].
LGF308 (0.1-10 μM; 12 h) induces BRD4/BD1 degradation in BD1-HEK293T and CRISPRi HEK293T cells that is DCAF11-dependent[1].
LGF308 (1 μM; 6 h) promotes formation of a ternary complex between BD1 and DCAF11 in HEK293T cells[1].
LGF308 (gradient concentrations; 48 h) selectively inhibits proliferation of breast cancer cell lines, with the highest potency in MDA-MB-468 cells (IC50 = 0.70 μM) and lower potency in normal HEK293T cells (IC50 = 16.01 μM) after 48 h treatment[1].
LGF308 (1 μM) induces apoptosis in MDA-MB-231 cells, as shown by upregulated c-PARP-1 and c-Caspase-7 levels[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: MDA-MB-231 cells
Concentration: 0.1 μM, 0.5 μM, 1 μM, 2 μM, 5 μM (9 h treatment); 1 μM (3 h, 6 h, 9 h treatments)
Incubation Time: 3 h, 6 h, 9 h (1 μM treatment); 9 h (0.1-5 μM treatments)
Result: Reduced BRD4 levels to ~60% of control after 3 h of 1 μM treatment.
Dropped BRD4 levels to ~40% of control by 6 h of 1 μM treatment.
Degraded over 90% of both long and short BRD4 isoforms at 5 μM, with a DC50 of 0.50 μM for the long isoform and 0.23 μM for the short isoform.

Cell Proliferation Assay[1]

Cell Line: MCF-7, T-47D, MDA-MB-231, MDA-MB-157, MDA-MB-468, HCC1937, BT-549 (breast cancer cell lines), HEK293T (normal cell line)
Concentration: Gradient concentrations
Incubation Time: 48 h
Result: Inhibited proliferation of breast cancer cell lines with IC50 values of 2.86 μM (MCF-7), 2.22 μM (T-47D), 1.31 μM (MDA-MB-231), 3.10 μM (MDA-MB-157), 0.70 μM (MDA-MB-468), 1.45 μM (HCC1937), 1.60 μM (BT-549).
Resulted in an IC50 of 16.01 μM for normal HEK293T cells, significantly higher than cancer cell lines.
Parmacokinetics
Species Dose Route T1/2 Vdss MRT0-inf CL Cmax AUC0-t AUC0-∞
Rat[1] 3 mg/kg i.v. 3.84 h 0.08 L/kg 1.72 h 0.73 mL/min/kg 30,833.3 ng/mL 114,985 115,124
Molecular Weight

732.27

Formula

C35H34ClN7O5S2

CAS No.
SMILES

O=C(N1CCCCCCNC(C[C@@H]2N=C(C3=C(N4C2=NN=C4C)SC(C)=C3C)C5=CC=C(C=C5)Cl)=O)/C(SC1=O)=C/C6=CC([N+]([O-])=O)=CC=C6

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
LGF308
Cat. No.:
HY-181756
Quantity:
MCE Japan Authorized Agent: